Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04172597
Title A Study of Poziotinib in Patients With EGFR or HER2 Activating Mutations in Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Spectrum Pharmaceuticals, Inc
Indications

Advanced Solid Tumor

breast cancer

colorectal cancer

malignant glioma

Therapies

Poziotinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST